Express Scripts 2012 Annual Report Download - page 19

Download and view the complete annual report

Please find page 19 of the 2012 Express Scripts annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 120

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120

Express Scripts 2012 Annual Report 17
ge
Mr. Ebling was named Executive Vice President, General Counsel and Secretary in December 2008. Mr. Ebling
served as Vice President of Business Development from April 2002 to December 2004 and from October 2007 to
December 2008 and as Vice President and General Counsel of our CuraScript subsidiary from January 2005 to October
2007.
Mr. Ignaczak was named Executive Vice President, Sales and Marketing in May 2008. From November 2007, he
served as Executive Vice President, Sales and Account Management. He was elected Senior Vice President, Sales and
Account Management in December 2002. Mr. Ignaczak joined us in April 1998 and served as the Vice President and
General Manager of our National Employer Division from April 1998 to December 2002.
Mr. McNamee was named Executive Vice President and Chief Operating Officer in January 2010. Prior to this
role, he served as Executive Vice President, Operations & Technology beginning in November 2007. He was elected Senior
Vice President, Operations & Technology, with responsibility for Client & Patient Services and Information Technology in
May 2007. Mr. McNamee joined us and was elected Senior Vice President and Chief Information Officer in February 2005.
Prior to joining us, Mr. McNamee worked for Misys Healthcare Systems, a healthcare technology company, as President
and General Manager, Physician Systems, from September 2003 to February 2005.
Available Information
We make available through our website (www.express-scripts.com) access to our annual report on Form 10-K,
quarterly reports on Form 10-Q, current reports on Form 8-K, all amendments to those reports (when applicable), and other
filings with the SEC. Such access is free of charge and is available as soon as reasonably practicable after such information
is filed with the SEC. In addition, the SEC maintains an Internet site (www.sec.gov) containing reports, proxy and
information statements, and other information regarding issuers filing electronically with the SEC (which includes us).
Information included on our website is not part of this annual report.
Forward Looking Statements and Associated Risks
Information we have included or incorporated by reference in this Annual Report on Form 10-K, and information
which may be contained in our other filings with the Securities and Exchange Commission (“the SEC”) and our press
releases or other public statements, contain or may contain forward-looking statements. These forward-looking statements
include, among others, statements of our plans, objectives, expectations (financial or otherwise) or intentions.
Our forward-looking statements involve risks and uncertainties. Our actual results may differ significantly from
those projected or suggested in any forward-looking statements. We do not undertake any obligation to release publicly any
revisions to such forward-looking statements to reflect events or circumstances occurring after the date hereof or to reflect
the occurrence of unanticipated events. Any number of factors could cause our actual results to differ materially from those
contemplated by any forward looking statements, including, but not limited to, the risks associated with the following:
STANDARD OPERATING FACTORS
Q our ability to remain profitable in a very competitive marketplace depends upon our continued ability to attract
and retain clients while maintaining our margins, to differentiate our products and services from those of our
competitors in the marketplace, and to develop and cross-sell new products and services to our existing clients
Q our failure to anticipate and appropriately adapt to changes or trends within the rapidly changing healthcare
industry
Q changes in applicable laws, rules or regulations, or their interpretation or enforcement, or the enactment of
new laws, rules or regulations, which apply to our business practices (past, present or future) or require us to
spend significant resources in order to comply or to make significant changes to our business operations
Q unfavorable or uncertain economic conditions, including high rates of unemployment, diminished health care
benefits, lower levels of consumer expenditures on health care related expenses, increased client demands with
respect to pricing or service levels, or disruptions in the credit markets
Q changes to the healthcare industry designed to manage healthcare costs or alter healthcare financing
practices
Q uncertainties regarding the implementation of Health Reform Laws
Q significant changes within the pharmacy provider marketplace, including the loss of or adverse change in our
relationship with one or more key pharmacy providers
Q our failure to execute on, or other issues arising under, certain key client contracts
Q changes relating to our participation in Medicare Part D, the loss of Medicare Part D eligible members, or our
failure to otherwise execute on our strategies related to Medicare Part D